Pharmacists can bridge gaps through education, inclusive care, and streamlined access.
Pharmacists play a vital role in multidisciplinary health care teams by enhancing medication safety, optimizing therapeutic outcomes, expanding medication access, reducing costs, and improving patient education.
The FDA has approved elacestrant (Orserdu) for the treatment of postmenopausal women or adult men with estrogen receptor–positive (ER+), HER2-negative, ESR1-mutated advanced or metastatic breast cancer with disease progression following at least 1 line of endocrine therapy.
Historically, colchicine has been used primarily in the management of gout; however, in 2023, the FDA approved Lodoco, a newly marketed colchicine product, for the management of cardiovascular disease.
The COVID-19 pandemic highlighted the importance of managing infections properly globally and the need for stewardship networks among partners.
M3P will be a financial lifeline for seniors while lowering certain pharmacy costs, but more education and tools are needed to make it successful with pharmacies and their customers.
Patients with MDD may also seek complementary or alternative therapies in the form of dietary supplements which might be perceived by patients to be natural and safer than medicinal agents.
This study found no significant difference in the sustained return of spontaneous circulation or survival to hospital discharge based on the timing of the first epinephrine administration in these patients.
Keri Bates, PharmD, shares how the nomination validates years of hard work, highlights the deep relationships built with the community, and inspires continued growth and innovation.
Vaccine administration provides benefits at the patient and public health levels, and pharmacists are critical members of health care teams that provide these vital biologic medications.
The demands of the pharmacy profession—long hours, high stress, and emotional strain—can take a toll on pharmacists’ well-being.
The Act is part of a federal attempt to streamline the research process for medical marijuana and provide more attainable security requirements
Many pharmacy professionals feel discouraged, underutilized, and undervalued, but the support staff often saves the day.
Bispecific therapies require clearer terminology to improve safety and communication.
How pharmacy teams can remove cost barriers to cardiac care.
Given the increasing value of patient satisfaction in determining the quality of care in the hospital reimbursement model, research is flourishing with a focus on identifying the factors that could positively influence patient satisfaction outcomes.
This article reviews the efficacy and safety data for bispecific T-cell engagers and the practical considerations for their implementation across various types of practice sites for the historically difficult-to-treat relapsed/refractory B-cell lymphoma population.
Data show these cases pose some of the most significant threats to patients and health systems.
With the organism’s potential to cause severe symptoms, severe disease, and possible death, it is essential to care for infected individuals promptly and safely.
One could also argue that the Great Resignation is an era for a great realignment. During lockdown, many individuals took the time to realign their priorities.
The DEA will have a hearing in December 2024 regarding the potential reclassification of cannabis to Schedule III, which could significantly impact the regulatory environment for pharmacies and their involvement in the cannabis market.
The expansion of roles is a testament to technicians' indispensable worth in safeguarding medication safety and promoting the profession.
AI systems can detect minute anomalies often missed by the human eye, reducing false negatives.
Experts discussed the promising future of pericarditis treatment.
Without a constitutional right to abortion, mail order pharmacy providers need to consider both the federal requirements and various state laws in how they approach the dispensing of mifepristone across state lines.
Cephalosporins are commonly prescribed in the outpatient setting; understanding differences among them is important for pharmacists.
Product verification allows technicians to practice at the top of their license and frees pharmacists to interact with patients.
Real-world metrics demonstrate that using health-system specialty pharmacies (HSSPs) means everyone wins: health systems, clinicians, and patients.
The therapy offers new hope in solid tumor treatment with fewer adverse effects.